دورية أكاديمية

Surgical resection and survival outcomes in metastatic young adult colorectal cancer patients.

التفاصيل البيبلوغرافية
العنوان: Surgical resection and survival outcomes in metastatic young adult colorectal cancer patients.
المؤلفون: Arhin, Nina D., Shen, Chan, Bailey, Christina E., Matsuoka, Lea K., Hawkins, Alexander T., Holowatyj, Andreana N., Ciombor, Kristen K., Hopkins, Michael B., Geiger, Timothy M., Kam, Audrey E., Roth, Marc T., Lebeck Lee, Cody M., Lapelusa, Michael, Dasari, Arvind, Eng, Cathy
المصدر: Cancer Medicine; Jul2021, Vol. 10 Issue 13, p4269-4281, 13p
مصطلحات موضوعية: COLORECTAL cancer, SURVIVAL rate, YOUNG adults, CANCER patients, OVERALL survival, SURGICAL excision
مستخلص: Background: The incidence of colorectal cancer in adults younger than age 50 has increased with rates expected to continue to increase over the next decade. The objective of this study is to examine the survival benefit of surgical resection (primary and/or metastatic) versus palliative therapy in this patient population. Methods: We identified 6708 young adults aged 18–45 years diagnosed with metastatic colorectal cancer (mCRC) from 2004 to 2015 from the SEER database. Overall survival (OS) was analyzed using Kaplan–Meier estimation, log rank test, and multivariate Cox proportional hazards model. Results: Sixty‐three percent of patients in our study underwent primary tumor resection (PTR), with 40% undergoing PTR alone and 23% undergoing both resection of primary disease and metastasectomy. The median OS for patients who underwent both PTR and metastasectomy was 36 months, compared to 13 months for those who did not receive any surgical intervention. The multivariate analysis showed significant OS benefit of receiving both PTR and metastasectomy (HR 0.34, 95% CI: 0.31–0.37, p < 0.001) compared to palliative therapy. Undergoing PTR only and metastasectomy only were also associated with improved OS (HR 0.46, 95% CI: 0.43–0.49, p < 0.001 and HR 0.64, 95% CI: 0.55–0.76, p < 0.001, respectively). Conclusion: This is the largest observational study to evaluate survival outcomes in young‐onset mCRC patients and the role of surgical intervention of the primary and/or metastatic site. Our study provides evidence of statistically significant increase in OS for young mCRC patients who undergo surgical intervention of the primary and/or metastatic site. [ABSTRACT FROM AUTHOR]
Copyright of Cancer Medicine is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
قاعدة البيانات: Complementary Index
الوصف
تدمد:20457634
DOI:10.1002/cam4.3940